In our previous work it was found that in cystic fibrosis patients with and without pancreatic insufficiency, the fatty acid pattern of the plasma long chain, non-esterified fatty acid fraction is strikingly abnormal in comparison with the corresponding pattern of healthy subjects. However, other in
Genetic differences in cystic fibrosis patients with and without pancreatic insufficiency
β Scribed by Maurizio Ferrari; Mariano Antonelli; Fiorenza Bellini; Graziella Borgo; Ornella Castiglione; Lauretta Curcio; Bruno Dallapiccola; Marcella Devoto; Xavier Estivill; Paolo Gasparini; Annamaria Giunta; Lore Marianelli; Gianni Mastella; Giuseppe Novelli; Pierfranco Pignatti; Luca Romano; Giovanni Romeo; Manuela Seia; Robert Williamson
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 447 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
β¦ Synopsis
To determine the number and frequency of mutations that occur at the cystic fibrosis locus (CF), we have examined the allele and haplotype frequencies of eight polymorphic DNA markers linked to CF in 163 Italian patients who were sub-divided according to their clinical presentations. The distribution of haplotypes for the tightly linked polymorphisms KM.19 and XV-2c differ significantly between patients with and those without pancreatic insufficiency. The haplotype found most commonly in CF chromosomes occurs much more frequently in pancreatic insufficient than in pancreatic sufficient patients. Among the 19 pancreatic sufficient patients, 6 (31.6%) show at least one copy of the rare KM.19 = 1, XV-2c = 2 haplotype, as against 16 of 138 patients (11.6%) with pancreatic insufficiency. In addition, only 5 pancreatic sufficient patients (26.3%) are homozygous for the common 2,1 haplotype, as compared with 88 patients (63.8%) with pancreatic insufficiency. These findings support the hypothesis of allelic heterogeneity at a single locus in CF and suggest that different mutations underlie the presence or absence of pancreatic insufficiency in this disorders.
π SIMILAR VOLUMES
## Communicated by liirgm Horst Cystic fibrosis (CF) is caused by mutations in the gene for the cystic fibrosis transmembrane conductance regulator (CFTR) that codes for a CAMP-regulated chloride channel. The R347P is a missense mutation located within the first membrane spanning domain (MSD1) of